关于"使用MASLD多基因风险评分进行人口分层,通过临床纤维化评分改善严重肝病的预测"的评论
Zhiyao Shi1, Kai Feng1, Xiaokun Yang1
1The First Clinical College, Shanxi University of Traditional Chinese Medicine, Taiyuan, China.
概括
No abstract available in PubMed .
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.0K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.8K
